Rain Therapeutics (RAIN) PT Raised to $12 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts RAIN Hot Sheet
Price: $0.92 -5.15%
Rating Summary:
2 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
2 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Mitchell Kapoor raised the price target on Rain Therapeutics (NASDAQ: RAIN) to $12.00 (from $10.00) while maintaining a Buy rating.
You May Also Be Interested In
- Rain Enhancement Technologies Reports Business Progress, Hosts Webcast Today
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
